CE marked, FDA cleared, NMPA approved
• High Generalization Ability and Rigorous Clinical Validation.
• Efficient Analysis and High Sensitivity: effective for small nodules, improving efficiency and accuracy.
• Intelligent Follow-up and Treatment Efficacy Evaluations: auto-analysis based on relevant priors to compare nodule development and improve treatment outcomes.
• Intelligent Case Database: search for similar cases in the database, providing an intelligent reference for clinical decision making.
• Structured Reporting: automatic report generation in accordance with professional guidelines.